Pyxis Oncology ( NASDAQ:PYXS – Get Free Report ) posted its quarterly earnings data on Thursday. The company reported ($0.24) EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.03, FiscalAI reports.
Pyxis Oncology Trading Down 3.0%
Shares of NASDAQ:PYXS traded down $0.05 during trading on Thursday, hitting $1.61. 1,149,574 shares of the company’s stock were exchanged, compared to its average volume of 834,470. Pyxis Oncology has a 1-year low of $1.03 and a 1-year high of $5.55. The firm has a 50-day moving average price of $2.54 and a two-hundred day moving average price of $2.16. The firm has a market cap of $134.29 million, a P/E ratio of -1.14 and a beta of 1.41.
Get Pyxis Oncology alerts:
Analysts Set New Price Targets
A number of analysts have recently weighed in on the company. HC Wainwright raised their target price on Pyxis Oncology from $7.00 to $8.00 and gave the company a “buy” rating in a research note on Thursday, September 10th. Stifel Nicolaus set a $5.00 price target on shares of Pyxis Oncology in a research report on Thursday. Wedbush upped their price target on shares of Pyxis Oncology from $6.00 to $8.00 and gave the stock an “outperform”...